AXL phosphorylation and activation by binding of GAS6 has been associated with increased cell proliferation and survival in various tissues and cancer types including prostate cancer [25,26], colorectal cancer [27], gastric cancer [28], renal carcinoma and osteosarcoma [29,30]. This evidence concerns the gene GAS6 and Familial prostate cancer.